Does the loss of the tumour-suppressor miR-145 result in the shorter disease-free survival of prostate cancer patients?
The loss of the tumour-suppressor miR-145 increases the risk for disease progression and predicts the poor survival of PCa patients.
An increased BMI is associated with higher RR of DLBCL regardless of sex. Also, there seems to be a linear association between BMI and DLBCL incidence.